Literature DB >> 9207417

Tobacco smoking and risk of haematological malignancies in adults: a case-control study.

P Pasqualetti1, V Festuccia, P Acitelli, A Collacciani, A Giusti, R Casale.   

Abstract

A retrospective study was conducted in 1216 cases to investigate the possible association between tobacco smoking and the risk of haematological malignancies. A small, but not significant, increase in malignancy was observed in smokers. Significant association was demonstrated between tobacco smoking and acute nonlymphoblastic leukaemia, and myelodysplastic syndromes. The duration and amount smoked increased the risk; heavy smokers presented significant positive associations with overall malignancies, acute nonlymphoblastic leukaemia, myelodysplastic syndromes, and monoclonal gammopathy of undetermined significance, whereas light smokers did not present any significant association. These data support a causal relationship between certain haematological malignancies and tobacco smoking. Further research is needed to examine the risk according to dose-response effect, and the variation in risk according to the histological subtype of the malignancy.

Entities:  

Mesh:

Year:  1997        PMID: 9207417     DOI: 10.1046/j.1365-2141.1997.942910.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Precursors to lymphoproliferative malignancies.

Authors:  Lynn R Goldin; Mary L McMaster; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

2.  Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.

Authors:  Maira A Castaneda-Avila; Christine M Ulbricht; Mara Meyer Epstein
Journal:  Ann Hematol       Date:  2021-01-08       Impact factor: 3.673

Review 3.  Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.

Authors:  Rishi K Wadhera; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2010-08-16       Impact factor: 7.616

4.  Alcohol use is not a significant contributor to myelodysplastic syndromes.

Authors:  Elizabeth A Duffy; Phuong L Nguyen; Adina Cioc; Erica Warlick; Michelle A Roesler; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2020-04-13       Impact factor: 2.506

5.  Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.

Authors:  Xiaomei Ma; Unhee Lim; Yikyung Park; Susan T Mayne; Rong Wang; Patricia Hartge; Albert R Hollenbeck; Arthur Schatzkin
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

6.  A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes.

Authors:  Hongyan Tong; Chao Hu; Xiufeng Yin; Mengxia Yu; Jun Yang; Jie Jin
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes.

Authors:  Archita Das; Neekkan Dey; Arunava Ghosh; Tanusree Das; Indu B Chatterjee
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

8.  Tobacco and the risk of acute leukaemia in adults.

Authors:  E V Kane; E Roman; R Cartwright; J Parker; G Morgan
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.

Authors:  A V Moorman; E Roman; R A Cartwright; G J Morgan
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).

Authors:  Rina Yarosh; Michelle A Roesler; Thomas Murray; Adina Cioc; Betsy Hirsch; Phuong Nguyen; Erica Warlick; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.